Notice of Intent to Sole Source- Georgia Drug and Narcotics Agency (GDNA)
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Food and Drug Administration (FDA) has issued a Notice of Intent (NOI) to award a sole source contract to the Georgia Drug and Narcotics Agency (GDNA) for investigative services in Atlanta, GA. This is not a request for competitive proposals, but interested parties may submit capability statements. Responses are due April 3, 2026, at 10:00 AM EST.
Purpose & Scope
The FDA intends to procure investigative services specifically for the Georgia Drug and Narcotics Agency (GDNA). The purpose of this notice is to inform the public of this intent and to allow other sources to demonstrate their capability to meet the requirement, which may lead to a competitive procurement.
Contract Details
- Type: Notice of Intent to Sole Source
- Period of Performance: 12 months from the date of contract award.
- NAICS Code: 922120 – Police Protection
- PSC Code: R499 – Other Professional Services
- Authority: 10 U.S.C. 2304(c)(5), as authorized by statute.
- Place of Performance: Atlanta, GA.
Set-Aside
This is a sole source action; therefore, no set-aside applies.
Submission & Evaluation
This notice is not a solicitation for competitive proposals. However, interested parties may submit a capability statement demonstrating their ability to meet the Government’s requirement. All responses received by the deadline will be considered by the Government for the purpose of determining whether to conduct a competitive procurement. A determination not to compete is solely at the Government's discretion. The Government will not be responsible for any costs incurred by responding to this notice.
Key Dates
- Published Date: March 31, 2026
- Responses Due: April 3, 2026, at 10:00 AM Eastern Standard Time (EST)
Contact Information
- Primary Contact: Nina Montgomery
- Email: Nina.Montgomery@fda.hhs.gov